Clinical Trial Detail

NCT ID NCT03088930
Title Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors University of Colorado, Denver
Indications

non-small cell lung carcinoma

Therapies

Crizotinib

Age Groups: adult senior

Additional content available in CKB BOOST